Dyax (DYAX)
Dyax Market Cap: 168.95M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
DYAX Market Cap Rankings
| Overall | 31st percentile | 3200 of 4649 |
| Sector | 41st percentile | 305 of 525 in Healthcare |
| Industry | 48th percentile | 85 of 164 in Biotechnology |
DYAX Market Cap Range, Past 5 Years
| Minimum | 124.42M | Sep 2011 |
| Maximum | 324.43M | Mar 2010 |
| Average | 207.92M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these DYAX related companies
DYAX News
Dyax Corp. Reaffirms Commitment to Supporting Patients with Hereditary Angioedema on Inaugural HAE Day
May 16, 8:00AM Business Wire
May 16, 8:00AM Business Wire
Dyax Corp. Launches Hereditary Angioedema (HAE) Attack Tracker™, a Free iPhone Application for HAE Patients
May 11, 7:12AM Business Wire
May 11, 7:12AM Business Wire
Dyax's CEO Presents at Deutsche Bank AG Health Care Conference (Transcript)
May 07, 3:19PM Seeking Alpha
May 07, 3:19PM Seeking Alpha
Dyax Corp. to Participate in the Deutsche Bank 37th Annual Healthcare Conference
May 01, 7:12AM Business Wire
May 01, 7:12AM Business Wire
Listen to $DYAX Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3UWf
about 35 days ago by earningscast
about 35 days ago by earningscast
$DYAX filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3JEm
about 48 days ago by MarketBrief
about 48 days ago by MarketBrief
Dyax Corp. to Participate in the Needham & Company 11th Annual Healthcare Conference
Mar 27, 7:12AM Business Wire
Mar 27, 7:12AM Business Wire
KALBITOR® (ecallantide) Data Presented at American Academy of Allergy, Asthma and Immunology Annual Meeting
Mar 06, 7:12AM Business Wire
Mar 06, 7:12AM Business Wire
Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer
Feb 29, 7:15AM Business Wire
Feb 29, 7:15AM Business Wire
$DYAX http://stks.co/2Z1D tiny BIOTECH in bottoming mode for months, watching closely - $DYAX
about 92 days ago by LTbioinvestor
about 92 days ago by LTbioinvestor
Listen to $DYAX Q4 2011 earnings call - live at 05:00 PM, ondemand after - http://stks.co/2WDu
about 96 days ago by earningscast
about 96 days ago by earningscast
Dyax Corp. Announces Fourth Quarter and Full Year 2011 Financial Results
Feb 22, 4:01PM Business Wire
Feb 22, 4:01PM Business Wire
Dyax Corp. to Host Fourth Quarter and Year End 2011 Earnings Call and Webcast
Feb 15, 7:00AM Business Wire
Feb 15, 7:00AM Business Wire
Dyax Corp Enters into New Loan Agreement with Cowen Healthcare Royalty Partners
Jan 04, 7:35AM Benzinga
Jan 04, 7:35AM Benzinga
Dyax Corp. Enters into New Loan Agreement with Cowen Healthcare Royalty Partners
Jan 04, 7:30AM Business Wire
Jan 04, 7:30AM Business Wire
Dyax (DYAX) Says Sigma-Tau's Taiwan, Singapore, South Korea KALBITOR Rights Eliminated
Dec 29, 4:44PM Street Insider
Dec 29, 4:44PM Street Insider
$DYAX http://chart.ly/9gfcamn 10 & 20 crossed 200, 40 & 50 on track to do same
about 337 days ago by Tr8r_x
about 337 days ago by Tr8r_x
NEW POST: "The Situation Sometimes Rewards Grenades" http://bit.ly/m13S8D $ALXA $DYAX $IBB $IWM $OGXI $ONTY $QCOR $SPY
about 351 days ago by chessNwine
about 351 days ago by chessNwine
BUY $DYAX ON THE FIRST CLOSE ABOVE 2.35 - CHECK THE BLOG - http://etf.typepad.com/blog/
about 364 days ago by SUPERSTOCKTIMER
about 364 days ago by SUPERSTOCKTIMER
BUY $DYAX ON THE FIRST CLOSE ABOVE 2.35 - CHECK THE BLOG - http://etf.typepad.com/blog/
about 364 days ago by SUPERSTOCKTIMER
about 364 days ago by SUPERSTOCKTIMER
BUY $DYAX ON THE FIRST CLOSE ABOVE 2.35 - CHECK THE BLOG - http://etf.typepad.com/blog/
about 364 days ago by SUPERSTOCKTIMER
about 364 days ago by SUPERSTOCKTIMER
BUY $DYAX ON THE FIRST CLOSE ABOVE 2.35 - CHECK THE BLOG - http://etf.typepad.com/blog/
about 365 days ago by SUPERSTOCKTIMER
about 365 days ago by SUPERSTOCKTIMER
BUY $DYAX ON THE FIRST CLOSE ABOVE 2.35 - CHECK THE BLOG - http://etf.typepad.com/blog/
about 365 days ago by SUPERSTOCKTIMER
about 365 days ago by SUPERSTOCKTIMER
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DYAX | 1.71 | -0.03 | -1.72% | 168.95M |
| DY | 20.67 | -0.03 | -0.14% | 693.07M |
| DRYS | 2.29 | +0.04 | +1.78% | 937.50M |
| DRWI | 3.04 | -0.01 | -0.33% | 108.13M |
| DRW | 24.87 | +0.01 | +0.04% | |
| DROOY | 6.15 | +0.02 | +0.33% | |
| DRN | 64.30 | -0.85 | -1.30% | |
| DRL | 1.45 | -0.04 | -2.68% | 186.04M |
| DRIV | 14.57 | +0.23 | +1.60% | 518.40M |
| DRI | 53.06 | -0.18 | -0.34% | 6.815B |